Evidence map›Paper›PMID 34191819›Full record

ArticlePloS one2021

Multi-site, multi-platform comparison of MRI T1 measurement using the system phantom.

Kathryn E Keenan, Zydrunas Gimbutas, Andrew Dienstfrey, Karl F Stupic, Michael A Boss, Stephen E Russek, Thomas L Chenevert, P V Prasad, Junyu Guo, Wilburn E Reddick and 10 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  12. Article
  13. Multi-center QA of ultrahigh-field systems.Magma (New York, N.Y.) · 2025
    Review
  14. Article
  15. Article
  16. A signal model for fat-suppressed TNMR in biomedicine · 2025
    Article
  17. Article
  18. Article
  19. Repeatability and reproducibility of rapid TImaging neuroscience (Cambridge, Mass.) · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kathryn E KeenanNational Institute of Standards and Technology, Boulder, Colorado, United State of America.ORCID 0000-0001-9070-5255
Zydrunas GimbutasNational Institute of Standards and Technology, Boulder, Colorado, United State of America.
Andrew DienstfreyNational Institute of Standards and Technology, Boulder, Colorado, United State of America.
Karl F StupicNational Institute of Standards and Technology, Boulder, Colorado, United State of America.
Michael A BossAmerican College of Radiology, Center for Research and Innovation, Philadelphia, Pennsylvania, United State of America.ORCID 0000-0002-9492-767X
Stephen E RussekNational Institute of Standards and Technology, Boulder, Colorado, United State of America.
Thomas L ChenevertUniversity of Michigan, Ann Arbor, Michigan, United State of America.
P V PrasadNorthShore University Health System, Evanston, Illinois, United State of America.
Junyu GuoSt. Jude Children's Research Hospital, Memphis, Tennessee, United State of America.
Wilburn E ReddickSt. Jude Children's Research Hospital, Memphis, Tennessee, United State of America.ORCID 0000-0002-1054-1201
Kim M CecilCincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine Cincinnati, Ohio, United State of America.ORCID 0000-0001-8233-5485
Amita Shukla-DaveMemorial Sloan Kettering Cancer Center, New York, New York, United State of America.
David Aramburu NunezMemorial Sloan Kettering Cancer Center, New York, New York, United State of America.
Amaresh Shridhar KonarMemorial Sloan Kettering Cancer Center, New York, New York, United State of America.
Michael Z LiuColumbia University Medical Center, New York, New York, United State of America.
Sachin R JambawalikarColumbia University Medical Center, New York, New York, United State of America.
Lawrence H SchwartzColumbia University Medical Center, New York, New York, United State of America.
Jie ZhengWashington University in St. Louis, St. Louis, Missouri, United State of America.
Peng HuUniversity of California, Los Angeles, California, United State of America.
Edward F JacksonUniversity of Wisconsin, Madison, Wisconsin, United State of America.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology TrialsR01CA190299 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MALYARENKO, DARIYA I. · 2015 to 2025
$6.4M
Quantitative imaging tools to derive DW-MRI oncological biomarkersU01CA211205 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI DAVE, AMITA, SCHWARTZ, LAWRENCE H · 2017 to 2021
$3.4M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA190299NCI NIH HHS U01 CA211205
6 · The paper itself

Abstract

Recent innovations in quantitative magnetic resonance imaging (MRI) measurement methods have led to improvements in accuracy, repeatability, and acquisition speed, and have prompted renewed interest to reevaluate the medical value of quantitative T1. The purpose of this study was to determine the bias and reproducibility of T1 measurements in a variety of MRI systems with an eye toward assessing the feasibility of applying diagnostic threshold T1 measurement across multiple clinical sites. We used the International Society of Magnetic Resonance in Medicine/National Institute of Standards and Technology (ISMRM/NIST) system phantom to assess variations of T1 measurements, using a slow, reference standard inversion recovery sequence and a rapid, commonly-available variable flip angle sequence, across MRI systems at 1.5 tesla (T) (two vendors, with number of MRI systems n = 9) and 3 T (three vendors, n = 18). We compared the T1 measurements from inversion recovery and variable flip angle scans to ISMRM/NIST phantom reference values using Analysis of Variance (ANOVA) to test for statistical differences between T1 measurements grouped according to MRI scanner manufacturers and/or static field strengths. The inversion recovery method had minor over- and under-estimations compared to the NMR-measured T1 values at both 1.5 T and 3 T. Variable flip angle measurements had substantially greater deviations from the NMR-measured T1 values than the inversion recovery measurements. At 3 T, the measured variable flip angle T1 for one vendor is significantly different than the other two vendors for most of the samples throughout the clinically relevant range of T1. There was no consistent pattern of discrepancy between vendors. We suggest establishing rigorous quality control procedures for validating quantitative MRI methods to promote confidence and stability in associated measurement techniques and to enable translation of diagnostic threshold from the research center to the entire clinical community.

Indexed as

Phantoms, ImagingHumansMagnetic Resonance ImagingReference ValuesReproducibility of Results

Identifiers

PMID34191819
PMCPMC8244851

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.